Atlas Trials

NMO Spectrum Disorder (NMOSD)

3 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch NMO Spectrum Disorder (NMOSD)

RecordFirmDate
Efficacy and Safety Study of Satralizumab (SA237) as Monotherapy to Treat Participants With Neuromyelitis Optica (NMO) and Neuromyelitis Optica Spectrum Disorder (NMOSD) (NCT02073279)Hoffmann-La Roche2014-08-05
Efficacy and Safety Study of Satralizumab (SA237) as Add-on Therapy to Treat Participants With Neuromyelitis Optica (NMO) and NMO Spectrum Disorder (NMOSD) (NCT02028884)Hoffmann-La Roche2014-02-20

Track NMO Spectrum Disorder (NMOSD) automatically

Every clearance here is in the API, with alerts when new ones post.